Rapid identification and sorting of viable virus-reactive CD4(+) and CD8(+) T cells based on antigen-triggered CD137 expression
- PMID: 18760281
- DOI: 10.1016/j.jim.2008.07.017
Rapid identification and sorting of viable virus-reactive CD4(+) and CD8(+) T cells based on antigen-triggered CD137 expression
Abstract
Current methods for the detection and isolation of antigen-specific CD4(+) and CD8(+) T cells require the availability of peptide/MHC multimers or are restricted to cells that produce cytokines after antigen contact. Here we show that de novo cell surface expression of the TNF-receptor family member CD137 (4-1BB) identifies recently activated, but not resting, human CD4(+) and CD8(+) memory T cells. Maximum CD137 expression level is uniformly observed in both T-cell subsets at 24h after stimulation with antigen. In experiments with CMV and EBV-reactive T cells, we confirmed the specificity of CD137 expression by co-staining with peptide/HLA tetramers. Substantial proportions of CD137(+) T cells did not produce IFN-gamma, suggesting that CD137 detects a broader repertoire of antigen-specific T cells. Activated CD137(+) T cells could be easily purified by MACS and expanded in vitro thereafter. This CD137-based enrichment method was capable of isolating 2-fold higher numbers of anti-viral CD4(+) and CD8(+) T cells compared to the IFN-gamma secretion assay. In conclusion, antigen-triggered CD137 expression allows the rapid detection and sorting of virus-reactive CD4(+) and CD8(+) T cells. The CD137 assay is most attractive for the simultaneous targeting of anti-viral T helper and effector cells in monitoring studies and adoptive immunotherapy trials.
Similar articles
-
Simultaneous isolation of CD8(+) and CD4(+) T cells specific for multiple viruses for broad antiviral immune reconstitution after allogeneic stem cell transplantation.J Immunother. 2011 Apr;34(3):307-19. doi: 10.1097/CJI.0b013e318213cb90. J Immunother. 2011. PMID: 21389867
-
Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cells.J Immunother. 2006 Jul-Aug;29(4):436-43; discussion 365-6. doi: 10.1097/01.cji.0000211302.52503.93. J Immunother. 2006. PMID: 16799339
-
Soluble recombinant CMVpp65 spanning multiple HLA alleles for reconstitution of antiviral CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation.J Immunother. 2010 Jan;33(1):60-72. doi: 10.1097/CJI.0b013e3181b56dcc. J Immunother. 2010. PMID: 19952955
-
Cytomegalovirus (CMV)-specific cellular immune responses.Hum Immunol. 2004 May;65(5):500-6. doi: 10.1016/j.humimm.2004.02.012. Hum Immunol. 2004. PMID: 15172450 Review.
-
Cytomegalovirus (CMV)-specific CD8+ T cells in individuals with HIV infection: correlation with protection from CMV disease.J Antimicrob Chemother. 2006 Apr;57(4):585-8. doi: 10.1093/jac/dkl049. Epub 2006 Feb 27. J Antimicrob Chemother. 2006. PMID: 16504998 Review.
Cited by
-
Applications of cell therapy in the treatment of virus-associated cancers.Nat Rev Clin Oncol. 2024 Oct;21(10):709-724. doi: 10.1038/s41571-024-00930-x. Epub 2024 Aug 19. Nat Rev Clin Oncol. 2024. PMID: 39160243 Review.
-
Defining T cell receptor repertoires using nanovial-based binding and functional screening.Proc Natl Acad Sci U S A. 2024 Apr 2;121(14):e2320442121. doi: 10.1073/pnas.2320442121. Epub 2024 Mar 27. Proc Natl Acad Sci U S A. 2024. PMID: 38536748 Free PMC article.
-
Polyfunctional donor-reactive T cells are associated with acute T-cell-mediated rejection of the kidney transplant.Clin Exp Immunol. 2023 Oct 13;213(3):371-383. doi: 10.1093/cei/uxad041. Clin Exp Immunol. 2023. PMID: 37070703 Free PMC article.
-
Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection.Front Pediatr. 2023 Mar 27;11:1020865. doi: 10.3389/fped.2023.1020865. eCollection 2023. Front Pediatr. 2023. PMID: 37051428 Free PMC article.
-
An optimized flow cytometry protocol for simultaneous detection of T cell activation induced markers and intracellular cytokines: Application to SARS-CoV-2 immune individuals.J Immunol Methods. 2023 Apr;515:113443. doi: 10.1016/j.jim.2023.113443. Epub 2023 Feb 24. J Immunol Methods. 2023. PMID: 36842524 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous